MITIE Group PLC (MTO), the UK's leading facilities management and professional services company, has disclosed that JPMorgan Chase & Co. crossed a significant voting rights threshold in the business as of 17 November 2026. A TR-1 major holdings notification filed with the London Stock Exchange on 19 November 2026 reveals that JPMorgan Chase & Co.'s combined position reached 7.683490% of total voting rights in MITIE. The disclosure, made under DTR5 rules, is a regulatory requirement triggered whenever a holder crosses a notifiable threshold, and investors may be watching the composition of that stake closely.

Key Points

  • MITIE Group PLC (MTO), UK-listed facilities management and professional services provider
  • JPMorgan Chase & Co. crossed a voting rights threshold in MITIE on 17 November 2026, reaching a combined total of 7.683490%
  • The position comprises 0.621340% in direct shares and 7.062150% through cash-settled equity swaps; the previous notification stood at 7.502329% combined
  • Investors may be watching whether JPMorgan's position changes further, given the range of swap expiry dates extending to January 2028

JPMorgan Chase & Co. Holds 100,023,033 Voting Rights in MITIE as of 17 November 2026

According to the TR-1 notification, JPMorgan Chase & Co. held a total of 100,023,033 voting rights in MITIE Group PLC on the date the threshold was crossed. Of this, 8,088,553 voting rights were held as direct shares, equating to 0.621340% of MITIE's total voting rights. The remaining 91,934,480 voting rights, representing 7.062150%, were held through a series of cash-settled equity swaps under DTR5.3.1R.(1)(b), structured across multiple expiry dates between December 2026 and January 2028. The notification identifies J.P. Morgan Securities PLC as the relevant shareholder entity through which a material portion of the position is held.

Cash-Settled Equity Swaps Dominate JPMorgan's MITIE Exposure Across Multiple Expiry Dates

The announcement details an extensive portfolio of cash-settled equity swaps comprising the bulk of JPMorgan's economic exposure to MITIE. Individual swap tranches range in size from 13,663 voting rights, expiring 15 December 2026, to a single tranche of 23,152,843 voting rights expiring 23 August 2027. Because these instruments are cash-settled rather than physically settled, they do not confer direct voting rights on the holder, though they carry economic exposure to MITIE's share performance. This structure is common among large institutional market makers and investment banks managing client hedging and trading books.

MITIE Group's Position as a Major UK Facilities Management Provider Underpins Institutional Interest

MITIE Group PLC operates across the UK, delivering facilities management, security, engineering, and care services to both public and private sector clients. The company serves government departments, healthcare providers, infrastructure operators, and commercial businesses. Its revenue model is primarily contract-based, providing a degree of income visibility. MITIE's scale and listed status on the London Stock Exchange make it a constituent tracked by institutional investors and investment banks alike, which may partly explain JPMorgan's multi-tranche structured exposure to the stock across its various subsidiaries.

Previous JPMorgan Notification Stood at 7.502329% Before Latest Threshold Crossing

The TR-1 form records that JPMorgan Chase & Co.'s previous major holding notification in MITIE stood at a combined 7.502329%, comprising 1.019317% in direct voting rights and 6.483012% through financial instruments. The latest disclosure represents an increase from that prior position, with the combined total rising to 7.683490%. The notification was completed in London on 19 November 2026, two days after the threshold date, in line with standard regulatory timelines. The ultimate controlling entity across all notified positions is identified as JPMorgan Chase & Co., with J.P. Morgan Securities PLC, J.P. Morgan SE, and J.P. Morgan Securities LLC named as controlled undertakings in the chain.